NAV4/27/2017 Chg.+0.5800 Type of yield Investment Focus Investment company
428.5400USD +0.14% reinvestment Equity Worldwide Bellevue Asset Mgmt. 

Monthly performance

  Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Total
2009 - - - 2.88 4.05 5.17 7.56 0.15 5.07 -10.89 6.76 0.37 -
2010 1.37 2.88 4.90 -1.65 -12.38 -3.44 3.02 -2.03 12.01 6.40 -4.72 7.46 +12.10%
2011 -2.91 0.16 0.92 8.13 0.01 -0.79 -2.10 -13.30 -7.02 5.96 0.39 2.95 -9.00%
2012 13.39 1.68 3.30 0.35 -0.58 3.74 3.80 1.95 5.67 -8.59 4.96 -0.58 +31.48%
2013 7.49 1.65 7.76 9.32 2.92 -3.92 14.70 -2.77 9.09 -3.21 8.20 0.98 +63.75%
2014 9.96 6.60 -10.90 -4.05 2.82 8.50 -1.15 11.32 -1.20 10.11 2.59 -0.70 +36.33%
2015 7.89 5.71 0.50 -3.89 9.81 -0.41 2.01 -11.59 -12.36 9.46 2.34 0.90 +7.63%
2016 -23.11 -5.21 4.49 3.99 3.33 -9.40 13.18 -2.83 2.91 -14.05 8.71 -3.95 -24.69%
2017 7.45 7.20 -0.52 1.30 - - - - - - - - -

Calculated values

  YTD 6 Months 1 Year 3 Years 5 Years
Volatility 17.73% 24.18% 24.57% 27.38% 25.27%
Sharpe ratio 3.47 1.55 0.29 0.36 0.73
Best month +7.45% +8.71% +13.18% +13.18% +14.70%
Worst month -3.95% -14.05% -14.05% -23.11% -23.11%
Maximum loss -5.78% -10.63% -20.50% -42.26% -42.26%
Outperformance +4.07% - +0.72% +12.71% +42.04%
 
All quotes in USD

Tranches

Name   Type of yield Repurchase p. 1 Year 3 Years
BB Adamant Biotech I USD reinvestment 455.0100 +7.67% +34.41%
BB Adamant Biotech I EUR reinvestment 560.8200 +12.06% +71.25%
BB Adamant Biotech I CHF reinvestment 398.9200 +10.08% +51.83%
BB Adamant Biotech I GBP reinvestment 372.8800 - -
BB Adamant Biotech B USD reinvestment 428.5400 +6.88% +31.45%
BB Adamant Biotech B CHF reinvestment 373.6900 +9.27% +48.50%
BB Adamant Biotech B EUR reinvestment 526.2400 +11.24% +67.48%

Performance

YTD  
+16.08%
6 Months  
+17.05%
1 Year  
+6.88%
3 Years  
+31.45%
5 Years  
+129.82%
Since start  
+242.83%
Year
2016
  -24.69%
2015  
+7.63%
2014  
+36.33%
2013  
+63.75%
2012  
+31.48%
2011
  -9.00%
2010  
+12.10%